{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:44:52Z","timestamp":1783586692076,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jcv.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T18:46:14Z","timestamp":1518720374000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Standardization of rubella immunoassays"],"prefix":"10.1016","volume":"102","author":[{"given":"C.","family":"Vauloup-Fellous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.02.006_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3181\/00379727-111-27750","article-title":"Recovery of rubella virus from army recruits","volume":"111","author":"Parkman","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jcv.2018.02.006_bib0010","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4049\/jimmunol.93.4.608","article-title":"Studies of rubella. ii. neutralization of the virus","volume":"93","author":"Parkman","year":"1964","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jcv.2018.02.006_bib0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJM196703092761006","article-title":"Rubella-virus hemagglutination-inhibition test","volume":"276","author":"Stewart","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"29","key":"10.1016\/j.jcv.2018.02.006_bib0020","first-page":"301","article-title":"Rubella vaccines: WHO position paper","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02121750","article-title":"False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure","volume":"161","author":"Haukenes","year":"1975","journal-title":"Med. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.99.4.785","article-title":"The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status","volume":"99","author":"Lennette","year":"1967","journal-title":"J. Immunol."},{"issue":"Suppl. 4","key":"10.1016\/j.jcv.2018.02.006_bib0035","first-page":"547","article-title":"Current status of rubella testing: a report based on data from the College of American Pathologists\u2019 surveys, 1978\u20131980","volume":"76","author":"Skendzel","year":"1981","journal-title":"Am. J. Clin. Pathol."},{"issue":"Suppl. 4","key":"10.1016\/j.jcv.2018.02.006_bib0040","first-page":"594","article-title":"Evaluation of assays for the detection of antibodies to rubella. A report based on data from the College of American Pathologists Surveys of 1982","volume":"80","author":"Skendzel","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2018.02.006_bib0045","series-title":"WHO Technical Report Series No 463.18. 1971","author":"W.H.O","year":"1971"},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0092-1157(75)90041-4","article-title":"The British standard for anti-rubella serum","volume":"3","author":"Clarke","year":"1975","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jcv.2018.02.006_bib0055","series-title":"Calibration of a Replacement Preparation for the Second International Standard for Anti-Rubella Serum, Human","first-page":"1","author":"Collaborative Study","year":"1996"},{"issue":"5","key":"10.1016\/j.jcv.2018.02.006_bib0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/JCM.21.5.793-795.1985","article-title":"Comparison of a simple latex agglutination test with hemolysis-in-gel, hemagglutination inhibition, and radioimmunoassay for detection of rubella virus antibodies","volume":"21","author":"Vaananen","year":"1985","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0065","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/513967","article-title":"Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations","volume":"175","author":"Matter","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2018.02.006_bib0070","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1093\/clinids\/7.Supplement_1.S157","article-title":"Challenge with rubella virus after loss of detectable vaccine-induced antibody","volume":"7","author":"Schiff","year":"1985","journal-title":"Rev. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity: defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2018.02.006_bib0080","series-title":"Evaluation of Performance Criteria for Multiple Component Test Products Intended for the Detection and Quantification of Rubella IgG Antibody","author":"Skendzel","year":"1992"},{"issue":"3","key":"10.1016\/j.jcv.2018.02.006_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmv.1890050308","article-title":"Rubella immunity by four different techniques: results of challenge studies","volume":"5","author":"Best","year":"1980","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.jcv.2018.02.006_bib0090","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/JCM.00383-16","article-title":"Assessing immunity to rubella virus: a plea for standardization of IgG (Immuno)assays","volume":"54","author":"Bouthry","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.jcv.2018.02.006_bib0095","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/JCM.30.3.633-641.1992","article-title":"Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter","volume":"30","author":"Dimech","year":"1992","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/JCM.00231-08","article-title":"Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter","volume":"46","author":"Dimech","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2018.02.006_bib0105","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1386-6532(06)80821-8","article-title":"Rubella dilemma: are patients being immunized unnecessarily?","volume":"36","author":"James","year":"2006","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CVI.00603-12","article-title":"Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays","volume":"20","author":"Dimech","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.00045-15","article-title":"Standardization of assays that detect anti-Rubella virus IgG antibodies","volume":"29","author":"Dimech","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.jcv.2018.02.006_bib0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.00688-12","article-title":"Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status","volume":"20","author":"Enders","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2018.02.006_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2015.11.022","article-title":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","volume":"74","author":"Huzly","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/JCM.16.1.82-85.1982","article-title":"Comparison of several test systems used for determination of rubella immune status","volume":"16","author":"Weissfeld","year":"1982","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.jcv.2018.02.006_bib0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JCM.13.5.850-854.1981","article-title":"Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus","volume":"13","author":"Shekarchi","year":"1981","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/JCM.21.2.161-163.1985","article-title":"Comparative evaluation of commercial rubella virus antibody kits","volume":"21","author":"Wittenburg","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2018.02.006_bib0145","unstructured":"Picone O, Bouthry E, Y B-O, Cordier AG, Nedellec S, A L, et al. Determination of Rubella Virus-Specific Humoral and Cell-Mediated Immunity in pregnant women with negative or equivocal Rubella-specific IgG. submitted."},{"issue":"5","key":"10.1016\/j.jcv.2018.02.006_bib0150","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2014.05.046","article-title":"Rubella monitoring in pregnancy as a means for evaluating a possible reemergence of rubella","volume":"211","author":"Hutton","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.jcv.2018.02.006_bib0155","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/adc.65.8.820","article-title":"Rubella reinfection","volume":"65","author":"Miller","year":"1990","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0928-0197(94)90005-1","article-title":"Rubella reinfection; role of neutralising antibodies and cell-mediated immunity","volume":"2","author":"O'Shea","year":"1994","journal-title":"Clin. Diagn. Virol."},{"issue":"8722","key":"10.1016\/j.jcv.2018.02.006_bib0165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0140-6736(90)92545-S","article-title":"Serological evidence of reinfection among vaccinees during rubella outbreak","volume":"336","author":"Cusi","year":"1990","journal-title":"Lancet"},{"issue":"8599","key":"10.1016\/j.jcv.2018.02.006_bib0170","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(88)92209-X","article-title":"Serological distinction between primary rubella and reinfection","volume":"1","author":"Morgan-Capner","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1651-2227.1994.tb13111.x","article-title":"Congenital rubella syndrome despite repeated vaccination of the mother: a coincidence of vaccine failure with failure to vaccinate","volume":"83","author":"Braun","year":"1994","journal-title":"Acta Paediatr."},{"issue":"6709","key":"10.1016\/j.jcv.2018.02.006_bib0180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bmj.299.6709.1217-b","article-title":"Fetal infection after maternal reinfection with rubella","volume":"299","author":"Gilbert","year":"1989","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.jcv.2018.02.006_bib0185","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM198811243192113","article-title":"Clinical rubella with virus transmission to the fetus in a pregnant woman considered to be immune","volume":"319","author":"Hornstein","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"6259","key":"10.1016\/j.jcv.2018.02.006_bib0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/bmj.282.6259.187","article-title":"Congenital rubella affecting an infant whose mother had rubella antibodies before conception","volume":"282","author":"Partridge","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0195","first-page":"337","article-title":"Subclinical rubella reinfection in vaccinated women with rubella-specific IgM response during pregnancy and transmission of virus to the fetus","volume":"17","author":"Forsgren","year":"1985","journal-title":"Scand. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01710747","article-title":"Congenital rubella syndrome after maternal reinfection","volume":"21","author":"Weber","year":"1993","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/148.4.639","article-title":"Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus","volume":"148","author":"O\u2019Shea","year":"1983","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0210","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/infdis\/138.6.877","article-title":"Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals","volume":"138","author":"Schluederberg","year":"1978","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2807\/esm.09.04.00459-en","article-title":"Epidemiology of rubella in Finland","volume":"9","author":"Davidkin","year":"2004","journal-title":"Euro Surveill."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0220","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.vaccine.2009.10.130","article-title":"Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programs","volume":"28","author":"Kakoulidou","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamapediatrics.2013.4342","article-title":"Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience","volume":"168","author":"Papania","year":"2014","journal-title":"JAMA Pediatr."},{"issue":"7","key":"10.1016\/j.jcv.2018.02.006_bib0230","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2018.02.006_bib0235","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/21645515.2015.1128600","article-title":"How to determine protective immunity in the post-vaccine era","volume":"12","author":"Charlton","year":"2016","journal-title":"Hum. Vaccine Immunother."},{"issue":"3","key":"10.1016\/j.jcv.2018.02.006_bib0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/CVI.13.3.380-386.2006","article-title":"Humoral immune response to primary rubella virus infection","volume":"13","author":"Wilson","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1386-6532(99)00048-7","article-title":"Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells","volume":"14","author":"Nedeljkovic","year":"1999","journal-title":"J. Clin. Virol."},{"issue":"1\u20132","key":"10.1016\/j.jcv.2018.02.006_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01314649","article-title":"Antibody response to wild rubella virus structural proteins following immunization with RA 27\/3 live attenuated vaccine","volume":"101","author":"Cusi","year":"1988","journal-title":"Arch. Virol."},{"issue":"1\u20132","key":"10.1016\/j.jcv.2018.02.006_bib0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01311038","article-title":"Immune responses to wild and vaccine rubella viruses after rubella vaccination","volume":"106","author":"Cusi","year":"1989","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0928-0197(97)00018-4","article-title":"Maturation of rubella IgG avidity over time after acute rubella infection","volume":"8","author":"Bottiger","year":"1997","journal-title":"Clin. Diagn. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1386-6532(01)00161-5","article-title":"Maturation of IgG avidity to individual rubella virus structural proteins","volume":"22","author":"Nedeljkovic","year":"2001","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0270","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.151.4.2041","article-title":"Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome","volume":"151","author":"Mauracher","year":"1993","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/infdis\/jiu604","article-title":"Identification of serologic markers for school-Aged children with congenital rubella syndrome","volume":"212","author":"Hyde","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004\u20132009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0285","first-page":"533","article-title":"A resurgence of congenital rubella in Australia?","volume":"27","author":"Forrest","year":"2003","journal-title":"Commun. Dis. Intell. Q. Rep."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0290","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1479-828X.2006.00553.x","article-title":"Factors associated with low immunity to rubella infection on antenatal screening","volume":"46","author":"Francis","year":"2006","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"8","key":"10.1016\/j.jcv.2018.02.006_bib0295","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2105\/AJPH.93.8.1274","article-title":"The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia","volume":"93","author":"Francis","year":"2003","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0300","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.287.4.464","article-title":"The changing epidemiology of rubella in the 1990: on the verge of elimination and new challenges for control and prevention","volume":"287","author":"Reef","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jcv.2018.02.006_bib0305","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/jmv.24818","article-title":"Screening for potential susceptibility to rubella in an antenatal population: a multivariate analysis","volume":"89","author":"Snell","year":"2017","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.jcv.2018.02.006_bib0310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.33321\/cdi.1999.23.30","article-title":"The epidemiology of rubella and congenital rubella in Australia, 1992\u20131997","volume":"23","author":"Sullivan","year":"1999","journal-title":"Commun. Dis. Intell."},{"issue":"15","key":"10.1016\/j.jcv.2018.02.006_bib0315","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.vaccine.2015.02.043","article-title":"Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain","volume":"33","author":"Vilajeliu","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jcv.2018.02.006_bib0320","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"23","key":"10.1016\/j.jcv.2018.02.006_bib0325","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.vaccine.2017.04.057","article-title":"Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008\u20132011","volume":"35","author":"Gilbert","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jcv.2018.02.006_bib0330","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.vaccine.2014.12.022","article-title":"Determining rubella immunity in pregnant Alberta women 2009\u20132012","volume":"33","author":"Lai","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0335","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2018.02.006_bib0340","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5694\/j.1326-5377.1982.tb124143.x","article-title":"Rubella screening and vaccination programme at a Melbourne maternity hospital: a five-year review","volume":"1","author":"Francis","year":"1982","journal-title":"Med. J. Aust."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2018.02.006_bib0345","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1093\/clinids\/7.Supplement_1.S123","article-title":"Cell-mediated immune response in rubella infections","volume":"7","author":"Buimovici-Klein","year":"1985","journal-title":"Rev. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2018.02.006_bib0350","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.30.9.2323-2329.1992","article-title":"Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C","volume":"30","author":"Chaye","year":"1992","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.jcv.2018.02.006_bib0355","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/521029","article-title":"Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination","volume":"196","author":"Jokinen","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2018.02.006_bib0360","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01320628","article-title":"Low level rubella immunity detected by ELISA and specific lymphocyte transformation","volume":"66","author":"Buimovici-Klein","year":"1980","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0264-410X(86)90090-3","article-title":"Effect of low level immunity on response to live rubella virus vaccine","volume":"4","author":"Vaananen","year":"1986","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jcv.2018.02.006_bib0370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00007611-199301000-00017","article-title":"Symptomatic rubella reinfection in an immune contact of a rubella vaccine recipient","volume":"86","author":"Wolf","year":"1993","journal-title":"South. Med. J."},{"issue":"2","key":"10.1016\/j.jcv.2018.02.006_bib0375","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3476(82)80114-5","article-title":"Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized","volume":"101","author":"Robinson","year":"1982","journal-title":"J. Pediatr."},{"issue":"15","key":"10.1016\/j.jcv.2018.02.006_bib0380","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jama.1984.03340390028023","article-title":"Serological response to rubella revaccination","volume":"251","author":"Serdula","year":"1984","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jcv.2018.02.006_bib0385","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:38:40Z","timestamp":1751405920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218300398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":77,"alternative-id":["S1386653218300398"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.02.006","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of rubella immunoassays","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}